Development and clinical value of programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy
© 2024. The Author(s)..
Programmed ventricular stimulation (PVS), a clinical tool introduced in the early 1980s, aims to prove the electrical vulnerability of the heart and, independent of spontaneous arrhythmia variability, to trigger arrhythmias under controlled conditions. A specific response is the inducibility of monomorphic sustained ventricular tachycardia. This depends on the underlying heart disease, e.g., only for coronary artery disease but not for nonischemic diseases. The value of pharmacologic arrhythmia control as serial electrical testing is uncertain. Up to now there seems to be no prognostic value of PVS concerning sudden cardiac death. PVS is used as a tool to monitor the results of ventricular tachycardia (VT)-catheter ablation in patients who were primarily inducible.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Herzschrittmachertherapie & Elektrophysiologie - 35(2024), Suppl 1 vom: 29. März, Seite 83-87 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Entwicklung und Bedeutung der programmierten Ventrikelstimulation bei der koronaren Herzerkrankung und dilatativen Kardiomyopathie |
|---|
| Beteiligte Personen: |
Gonska, Bernd-Dieter [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Arrhythmia control |
|---|
| Anmerkungen: |
Date Completed 11.03.2024 Date Revised 12.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00399-024-01003-3 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM369113187 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM369113187 | ||
| 003 | DE-627 | ||
| 005 | 20240312234023.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240301s2024 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1007/s00399-024-01003-3 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1324.xml |
| 035 | |a (DE-627)NLM369113187 | ||
| 035 | |a (NLM)38421398 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Gonska, Bernd-Dieter |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development and clinical value of programmed ventricular stimulation in coronary artery disease and dilated cardiomyopathy |
| 246 | 3 | 3 | |a Entwicklung und Bedeutung der programmierten Ventrikelstimulation bei der koronaren Herzerkrankung und dilatativen Kardiomyopathie |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 11.03.2024 | ||
| 500 | |a Date Revised 12.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2024. The Author(s). | ||
| 520 | |a Programmed ventricular stimulation (PVS), a clinical tool introduced in the early 1980s, aims to prove the electrical vulnerability of the heart and, independent of spontaneous arrhythmia variability, to trigger arrhythmias under controlled conditions. A specific response is the inducibility of monomorphic sustained ventricular tachycardia. This depends on the underlying heart disease, e.g., only for coronary artery disease but not for nonischemic diseases. The value of pharmacologic arrhythmia control as serial electrical testing is uncertain. Up to now there seems to be no prognostic value of PVS concerning sudden cardiac death. PVS is used as a tool to monitor the results of ventricular tachycardia (VT)-catheter ablation in patients who were primarily inducible | ||
| 650 | 4 | |a English Abstract | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Arrhythmia control | |
| 650 | 4 | |a Coronary artery disease | |
| 650 | 4 | |a Dilative cardiomyopathy | |
| 650 | 4 | |a Inducibility | |
| 650 | 4 | |a Programmed ventricular stimulation | |
| 773 | 0 | 8 | |i Enthalten in |t Herzschrittmachertherapie & Elektrophysiologie |d 1997 |g 35(2024), Suppl 1 vom: 29. März, Seite 83-87 |w (DE-627)NLM093694202 |x 1435-1544 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2024 |g number:Suppl 1 |g day:29 |g month:03 |g pages:83-87 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00399-024-01003-3 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2024 |e Suppl 1 |b 29 |c 03 |h 83-87 | ||